Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active SurveillanceNot Yet Recruiting
Sponsor: University Hospital Tuebingen
Cervical Intraepithelial Neoplasia Grade 2 (CIN2) · Cervical Intraepithelial Neoplasia Grade 2 · CIN2
Germany
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Systemic Sclerosis
United States, Belgium, Canada, France, Germany +5 more
- A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque PsoriasisActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Plaque Psoriasis
United States, Argentina, Australia, Austria, Belgium +8 more
- A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Prostatic Neoplasms
United States, Argentina, Australia, Brazil, Canada +13 more
- A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial HypertensionActive Not Recruiting
Sponsor: Actelion
Hypertension, Pulmonary
United States, Australia, Belarus, Belgium, Brazil +27 more
Sponsor: Novartis Pharmaceuticals
Atrial Fibrillation
United States, Canada, China, Germany, Netherlands +2 more
- Open-Label Extension of EDG-5506 in Participants With Becker Muscular DystrophyEnrolling By Invitation
Sponsor: Edgewise Therapeutics, Inc.
Becker Muscular Dystrophy
United States, Belgium, Denmark, France, Germany +5 more
- A Prospective Multicenter Cohort Study of Contemporary Menopausal Hormone Therapy and Cardiovascular OutcomesNot Yet Recruiting
Sponsor: Heinrich-Heine University, Duesseldorf
Hormone Replacement Therapy · Cardiovascular Diseases · Hormone Replacement Therapy, Post-Menopausal · Menopause
Germany
- A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 DiabetesActive Not Recruiting
Sponsor: Eli Lilly and Company
Obesity · Overweight · Type 2 Diabetes
United States, Argentina, China, Czechia, Germany +2 more
- A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKEActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Ischemic Stroke; Ischemic Attack, Transient
United States, Argentina, Australia, Austria, Belgium +42 more
- A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung CancerActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Carcinoma, Non-Small-Cell Lung
United States, Brazil, Canada, China, France +8 more
Sponsor: Janssen-Cilag Ltd.
Metastatic Hormone-sensitive Prostate Cancer
Austria, France, Germany, Greece, Spain +1 more
Sponsor: Janssen Research & Development, LLC
Carcinoma, Non-Small-Cell Lung
Austria, Belgium, Czechia, Germany, Israel +3 more
Sponsor: Occlutech International AB
Paravalvular Leak
France, Germany, Greece, Hungary, Spain +1 more
Sponsor: Iovance Biotherapeutics, Inc.
Cervical Carcinoma
United States, France, Germany, Italy, Netherlands +3 more
Sponsor: Neuravi Limited
Ischemic Stroke
Belgium, France, Germany, Ireland, Netherlands
- Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)Active Not Recruiting
Sponsor: Edgewise Therapeutics, Inc.
Becker Muscular Dystrophy
United States, Australia, Belgium, Denmark, France +7 more
- Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Head and Neck Neoplasms
United States, Argentina, Australia, Austria, Belgium +19 more
- A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's DiseaseActive Not Recruiting
Sponsor: Janssen-Cilag Ltd.
Fistulizing Crohns Disease · Perianal Crohns Disease
United States, Australia, Belgium, Canada, Czechia +18 more
- Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease PatientsActive Not Recruiting
Sponsor: Janssen-Cilag Ltd.
Crohn's Disease
United States, Australia, Belgium, Brazil, Canada +9 more
Sponsor: Janssen Research & Development, LLC
Colorectal Neoplasms
United States, Belgium, Brazil, Canada, China +17 more
- Study for AZD4360 in Participants With Advanced Solid TumoursActive Not Recruiting
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Cancer · Biliary Tract Cancer · Pancreatic Ductal Adenocarcinoma
United States, China, Germany, Japan, United Kingdom
- A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationActive Not Recruiting
Sponsor: Bristol-Myers Squibb
Hepatocellular Carcinoma · Liver Cancer
United States, Argentina, Australia, Austria, Belgium +20 more
Sponsor: Janssen Research & Development, LLC
Crohn Disease
United States, Austria, Belgium, Canada, China +12 more
Sponsor: Janssen Research & Development, LLC
Crohns Disease · Colitis, Ulcerative · Arthritis, Psoriatic · Arthritis, Juvenile
United States, Argentina, Australia, Brazil, China +11 more